Agenus | AGEN - 应收帐款人





应收帐款人 更改 日
AbbVie USD 12.59B 180M 2025-12
Agenus USD 22.44M 1.14M 2025-12
Amgen USD 9.14B 432M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Celldex Therapeutics USD 2.02M 1.92M 2025-12
CSL USD 4.32B 1.35B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
J&J USD 21.33B 3.72B 2025-12
Jiangsu Hengrui CNY 6.51B 569.71M 2026-03
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Merck EUR 4.44B 293M 2025-12
Merck USD 11.78B 345M 2025-12
Northwest Biotherapeutics USD 311K 299K 2025-09
Novartis USD 9.6B 2.69B 2026-03
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 15.84B 2.27B 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 44.66M 3.17M 2025-12